FDA approves injectable anti-emetic granisetron for chemotherapy patients
The US Food and Drug Administration (FDA) has approved granisetron for the prevention of nausea and vomiting caused by chemotherapy.
The injectable therapy, which is marketed as Sustol by Huron Therapeutics, is an antagonist to the 5-HT3 receptor.
Huron Therapeutics says Sustol is …